Medidata Solutions, Inc. (MDSO) Reports In-Line Q2 EPS; Boosts FY12 Outlook, Guides Q3; Gets Major Contract

July 31, 2012 6:39 AM EDT Send to a Friend
Get Alerts MDSO Hot Sheet
Trade MDSO Now!
Medidata Solutions, Inc. (NASDAQ: MDSO) reported Q2 EPS of $0.23, in-line with the analyst estimate of $0.23. Revenue for the quarter came in at $53.5 million versus the consensus estimate of $52.25 million.

Received $100 million contract with top ten pharma company.

The company now expects adjusted non-GAAP net income, which includes tax impact, primarily from stock-based compensation and amortization at a 40% effective tax rate, to be between $27.5 and $30.0 million, compared with prior guidance of between $27.0 and $30.0 million. Medidata Solutions, Inc. sees FY2012 revenue of $217-$219 million, versus prior guidance of $213-$217 million and the consensus of $215.11 million.

The company expects adjusted non-GAAP net income, which includes tax impact, primarily on stock-based compensation and amortization at a 40% effective tax rate, to be between $7.5 and $8.5 million. Medidata Solutions, Inc. sees Q3 2012 revenue of $55.5-$56.5 million, versus the consensus of $54.96 million.

For earnings history and earnings-related data on Medidata Solutions, Inc. (MDSO) click here.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Earnings, Guidance, Hot Corp. News, Hot Guidance

Related Entities

Earnings

Add Your Comment